NLRP3 and temporal lobe epilepsy: Collectively, our findings indicate that the anti-epileptic effects of ADSC-Exos appear primarily mediated through NLRP3 inflammasome-associated pyroptosis pathway modulation, offering new translational avenues for temporal lobe epilepsy therapy.